Candriam S.C.A. Merrimack Pharmaceuticals Inc Transaction History

Candriam S.C.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 07, 2018	SELL	$7.99 - $11.87 $159,800 - $237,399	-20,000 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$9.13 - $11.72 $182,600 - $234,400	20,000	20,000 $291,000

349

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.